These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20166791)

  • 1. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
    Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
    J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.
    Biederman J; Joshi G; Mick E; Doyle R; Georgiopoulos A; Hammerness P; Kotarski M; Williams C; Wozniak J
    CNS Neurosci Ther; 2010 Apr; 16(2):91-102. PubMed ID: 20415838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder.
    Biederman J; Mick E; Spencer T; Dougherty M; Aleardi M; Wozniak J
    Bipolar Disord; 2007 Dec; 9(8):888-94. PubMed ID: 18076539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents.
    Joshi G; Petty C; Wozniak J; Faraone SV; Spencer AE; Woodworth KY; Shelley-Abrahamson R; McKillop H; Furtak SL; Biederman J
    Psychopharmacology (Berl); 2013 Jun; 227(3):449-58. PubMed ID: 23397049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
    Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
    J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects.
    El-Mallakh RS; Salem MR; Chopra A; Mickus GJ; Penagaluri P; Movva R
    Ann Clin Psychiatry; 2010 Feb; 22(1):3-8. PubMed ID: 20196977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():19-22. PubMed ID: 16754408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
    Biederman J; Mick E; Spencer T; Doyle R; Joshi G; Hammerness P; Kotarski M; Aleardi M; Wozniak J
    CNS Spectr; 2007 Sep; 12(9):683-9. PubMed ID: 17805214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.